StemRIM (TSE:4599) FCF Yield % : 4.52 (As of Jun. 15, 2024)

View and export this data going back to 2019. Start your Free Trial

What is StemRIM FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, StemRIM's Trailing 12-Month Free Cash Flow is 円1,135 Mil, and Market Cap is 円25,101 Mil. Therefore, StemRIM's FCF Yield % for today is 4.52%.

The historical rank and industry rank for StemRIM's FCF Yield % or its related term are showing as below:

TSE:4599' s FCF Yield % Range Over the Past 10 Years
Min: -3.68 Med: 0 Max: 4.55
Current: 4.52

During the past 7 years, the highest FCF Yield % of StemRIM was 4.55%. The lowest was -3.68%. And the median was 0.00%.

TSE:4599's FCF Yield % is ranked better than
94.52% of 1552 companies
in the Biotechnology industry
Industry Median: -13.865 vs TSE:4599: 4.52

StemRIM's FCF Margin % for the quarter that ended in Apr. 2024 was 0.00%.

StemRIM FCF Yield % Historical Data

The historical data trend for StemRIM's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemRIM FCF Yield % Chart

StemRIM Annual Data

Trend

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

FCF Yield %

Get a 7-Day Free Trial

0.91

-1.56

-2.82

2.01

StemRIM Quarterly Data
	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
FCF Yield %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of StemRIM's FCF Yield %

For the Biotechnology subindustry, StemRIM's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

StemRIM's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, StemRIM's FCF Yield % distribution charts can be found below:

* The bar in red indicates where StemRIM's FCF Yield % falls into.

StemRIM FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

StemRIM's FCF Yield % for the fiscal year that ended in Jul. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	1134.965	/	56372.565
	=	2.01%

StemRIM's annualized FCF Yield % for the quarter that ended in Apr. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0	*	4	/	28662.7746
	=	0.00%

StemRIM FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

StemRIM FCF Yield % Related Terms

Thank you for viewing the detailed overview of StemRIM's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

StemRIM (TSE:4599) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemRIM Inc (TSE:4599) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085

Website

https://www.stemrim.com

StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.

StemRIM (TSE:4599) Headlines

No Headlines